Integer Holdings Corporation (ITGR)
NYSEHealth CareMedical - DevicesSnapshot 2026-11-05
$126.75+0.09%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · ITGR
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 10.2% |
| Our one-year growth estimate | diamond | 4.8% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 5.5 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 42 industry peers · Company calendar date is not available
ITGR — earnings miss
Dated 2026-10-29
Results of Operations and Financial Condition. On October 29, 2026, Integer Holdings Corporation issued a press release announcing its results for its third quarter ended October 2, 2026. A copy of the release is furnished with this report as Exhibit 99.1 and is incorporated by reference into this
Why it matters: The deal is still pending, and closing depends on remaining conditions. A delay or failed condition could change the deal outcome.
Watch forInteger files a closing notice by December 31, 2026. It confirms all other deal conditions are met or waived.
Also watch forInteger reports that a required approval or other closing condition is still unmet. Or it says the deal ended or was delayed past December 31, 2026.
Why it matters: This was Integer’s largest product line, but Q3 sales fell 5.1%. A return to growth would ease a clear business headwind.
Watch forA later quarterly report shows Cardio & Vascular sales were higher than in the same quarter last year.
Also watch forA later quarterly report shows Cardio & Vascular sales down 5.1% or more year over year again.
Why it matters: Q3 adjusted EBITDA fell 17%, while net debt rose to $1.223 billion. A smaller drop or growth would ease pressure on debt and earnings.
Worry ifA later quarter shows adjusted EBITDA fell 17% or more from a year earlier. Or the trailing leverage ratio was above 3.3 times.
Less concerning ifA later quarter shows adjusted EBITDA rose from a year earlier. The leverage ratio was 3.3 times or less.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$10 on $10,000 · ±0.1% | How much price usually moves either way. |
| Bad day | $236 loss on $10,000 · 2.4% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $724 loss on $10,000 · 7.2% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.